39. Shaolin| Link| Bookmark|
August 25, 2021 11:56:51 AM
Top Contributor (300+ Posts, 500+ Likes)
Covid Pandemic. Diagnostics businesses are at peak. IPO euphoria continues. It''s Party time for PE investors and Promoters to exit at peak valuations.
Though the Company is good and its business is running very well in Telangana & A.P. states but beware of peak valuations that may not sustain in Bear market conditions.
The IPO consists of a pure offer for sale of 35.69 million shares by its existing shareholders and promoters
Kedaara Capital backed Vijaya Diagnostic Center Ltd''s initial public offering will open on 1 September and close on 3 September.
The IPO consists of a pure offer for sale of 35.69 million shares by its existing shareholders and promoters.
An OFS comprises upto 5.1 million shares by Dr S Surenranath Reddy, upto 29.49 million shares by Karakoram Ltd, 1.10 million shares by Kedaara Capital Alternative Investment Fund - Kedaara Capital AIF I.
ICICI Securities, Edelweiss Financial Services and Kotak Mahindra Capital Co Ltd are the lead managers to the issue.
For fiscal year 2021, the company posted a revenue of Rs 376.75 crore versus Rs 338.82 crore a year ago. net profit for the year stood at Rs 84.91 crore against Rs 62.51 crore last year.
The firms bank balances are at Rs200.11 crore which are significantly higher than the debt outstanding of Rs 4.47 crore as of March 2021.
It is the largest integrated diagnostic chain in southern India, by operating revenue, and also one of the fastest-growing diagnostic chain by revenue for fiscal year 2020. It offers a one-stop solution for pathology and radiology testing services to our customers through our extensive operational network, which consists of 80 diagnostic centers and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh and in the National Capital Region and Kolkata.
The firm offer a comprehensive range of approximately 740 routine and 870 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines, as of March 2021.
37. krupa| Link| Bookmark|
August 25, 2021 9:30:44 AM
(800+ Posts, 500+ Likes)
Ksnaa diagnostic abhi bhi issue price ke niche struggle kar raha he Face value 5 Vijaya digno 1 paid up
35. A I| Link| Bookmark|
August 25, 2021 1:33:24 AM
(200+ Posts, 100+ Likes)
No point in applying these high price ipos if one is looking for listing gains. If one is going for long term then he can buy on listing day as most of the high price ipo have discount listing.
I booked losses in cartrade and Aptus. I am very conservative and have good experience of the market and dont apply IPO''s blindly. Somehow went greedy and applied to cartrade and Aptus and got my lessons. The moral of the story is; apply for IPO''s only when something is left on the table. Stay away from expensive issues.
That should not impact the share price. I did a mistake of selling Persistent Systems shares after its CEO resigned in Aug 2020. Since then the share price has more than tripled.
He was the CFO only from Dec 22, 2020. Shouldnt have any material impact
30. mann mundra| Link| Bookmark|
August 24, 2021 9:52:41 PM
Top Contributor (200+ Posts, 100+ Likes)
Face value 1 rs Only ofs Promoters selling stake in bull market. Means bahti ganga me hath dhone ke liye ready hai promoters . Krsnaa ka kya hashr hua sabhi jaante hai . Yadi high valuations par ipo aata hai to listing gain nhi hone wala hai . So be care full before applying . Bhav sahi to ipo acha nhi to yeh bhi flop jaane wala hai .
29. Eagleye| Link| Bookmark|
August 24, 2021 6:15:56 PM
IPO Guru (6600+ Posts, 21900+ Likes)
Vijaya Diagnostic ROC approval for RHP is received
Kotak Mahindra is one of the lead managers for this IPO also. And Vijaya Diagnostics by itself is costly compared to other Diagnostics. so, no chance of leaving any thing on table for retail investors. Fingers crossed for price band.
The most important for this company promoters and lead managers is to fix reasonable price and leave money on the table for the investors. Aggressive pricing and it will be dumped completely.
IPO Open : September 1, 2021 IPO Close : September 3, 2021 Basis of Allotment : September 8, 2021 Initiation of Refunds: September 9, 2021 Credit of Shares : September 13, 2021 IPO Listing Date : September 14, 2021
20. Eagleye| Link| Bookmark|
August 24, 2021 6:24:05 PM
IPO Guru (6600+ Posts, 21900+ Likes)